Develops insulin pumps for people with type 1 and type 2 diabetes.
Jun 2026Revenue $1.04B/yrExpenses $1.09B/yr
No trendCash runway over 10 years from Jun 2026
Figures by year
When will Tandem Diabetes Care be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $1.04B and expenses $1.09B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $1.01B | $1.20B | −$187M |
| Dec 2024 | $940M | $1.04B | −$99.1M |
| Dec 2023 | $748M | $981M | −$233M |
| Dec 2022 | $801M | $894M | −$92.8M |
| Dec 2021 | $703M | $680M | $22.7M |
| Dec 2020 | $499M | $507M | −$7.96M |
| Dec 2019 | $362M | $379M | −$16.7M |
| Dec 2018 | $184M | $228M | −$44.6M |
| Dec 2017 | $108M | $171M | −$62.9M |
| Dec 2016 | $84.2M | $162M | −$78.1M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.